← All stocks

ORTHOPEDIATRICS CORP

KIDS Net selling
CIK 0001425450 #2857 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$46.75M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$46.75M
21 of 21 sales
Net
−$46.75M
−$46.75M against sales at will

By person

17 insiders · 21 transactions
15.9×

David R. Bailey holds 15.9 times base salary in stock. $8.76M of shares against $550.00K in salary for 2025.

Salary from the company's own proxy. The shares are what David R. Bailey last reported holding, valued at $21.01, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Pelizzon David R
Director
$15.58M (7)
−$15.58M
13,109,612
50.21%
$275.43M
−4.9%
Pritzker Jennifer N.
10% owner
$15.58M (7)
−$15.58M
6,874,864
26.33%
$144.44M
−9.2%
Squadron Capital LLC entity
10% owner
$15.58M (7)
−$15.58M
6,201,764
23.75%
$130.30M
−10.1%
Bailey David R
President and CEO
417,160
1.60%
$8.76M
+81.5%
Hite Fred
COO and CFO
277,477
1.06%
$5.83M
+83.7%
Hauser Joseph W
Pres. Trauma & Def. Correction
194,767
0.7460%
$4.09M
+114.5%
Odle Gregory A
President of Scoliosis
187,735
0.7190%
$3.94M
+62.7%
Throdahl Mark C
Director
179,317
0.6868%
$3.77M
+12.4%
Gerritzen Daniel J
General Counsel and Secretary
147,054
0.5632%
$3.09M
+90.2%
Hughes Bryan W
Director
32,663
0.1251%
$686.25K
+154.7%
Riccitelli Samuel D
Director
31,859
0.1220%
$669.36K
+165.0%
Infante (Reynolds) Marie C
Director
31,202
0.1195%
$655.55K
+174.5%
Schlotterback Terry D
Director
26,619
0.1020%
$559.27K
+46.1%
McDonald Jimmy Duane
Director
24,568
0.0941%
$516.17K
+419.3%
Dyer George Sinclair Mitchell
Director
24,568
0.0941%
$516.17K
+419.3%
Ruf Harold
Director
19,837
0.0760%
$416.78K
Fischer Kelly Laine
Director
15,781
0.0604%
$331.56K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 12
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 0
History held since 16 Oct 2017